10-Q Filing

22ND CENTURY GROUP, INC. CIK: 1347858 Q3 2011

Filing Information

Form Type	10-Q
Accession Number	`0001144204-11-063724`
Period End Date	20110930
Filing Date	20111114
Fiscal Year	2011
Fiscal Period	Q3
XBRL Instance	xxii-20110930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 75 Income Statement 69 Cash Flow Statement 74 Stockholders Equity 11 Comprehensive Income 2

Balance Sheet 75 line items

Line Item	Tag	Value	Unit	Period
Authorized, preferred shares	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Authorized, preferred shares	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred shares, par value	`PreferredStockParOrStatedValuePerShare`	-	USD	Point-in-time
Preferred shares, par value	`PreferredStockParOrStatedValuePerShare`	-	USD	Point-in-time
Cash	`Cash`	$158.00	USD	Point-in-time
Cash	`Cash`	$4.38K	USD	Point-in-time
Cash	`Cash`	$1.29K	USD	Point-in-time
Authorized, common shares	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Authorized, common shares	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Cash	`Cash`	$310.00	USD	Point-in-time
Common shares, par value	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Common shares, par value	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$86.68K	USD	Point-in-time
Issued, preferred shares	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Grant receivable	`GrantsReceivableCurrent`	$223.54K	USD	Point-in-time
Issued, preferred shares	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Outstanding, preferred shares	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Outstanding, preferred shares	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Due from related Party	`DueFromRelatedPartiesCurrent`	$14.33K	USD	Point-in-time
Issued, common shares	`CommonStockSharesIssued`	27.21M	shares	Point-in-time
Inventory	`InventoryNet`	$833.40K	USD	Point-in-time
Issued, common shares	`CommonStockSharesIssued`	16.00M	shares	Point-in-time
Inventory	`InventoryNet`	$308.66K	USD	Point-in-time
Outstanding, common shares	`CommonStockSharesOutstanding`	27.21M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$211.72K	USD	Point-in-time
Outstanding, common shares	`CommonStockSharesOutstanding`	16.00M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$82.42K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$744.23K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.02M	USD	Point-in-time
Patent and trademark costs, net	`IntangibleAssetsNetExcludingGoodwill`	$1.47M	USD	Point-in-time
Patent and trademark costs, net	`IntangibleAssetsNetExcludingGoodwill`	$1.41M	USD	Point-in-time
Office Furniture and fixtures, net	`PropertyPlantAndEquipmentNet`	$8.32K	USD	Point-in-time
Deferred private placement costs	`DeferredCosts`	$587.13K	USD	Point-in-time
Deposits	`DepositsAssetsNoncurrent`	$1.53K	USD	Point-in-time
Total other assets	`AssetsNoncurrent`	$1.41M	USD	Point-in-time
Total other assets	`AssetsNoncurrent`	$2.06M	USD	Point-in-time
Total assets	`Assets`	$2.44M	USD	Point-in-time
Total assets	`Assets`	$2.80M	USD	Point-in-time
Demand bank loans	`ShortTermBankLoansAndNotesPayable`	$174.93K	USD	Point-in-time
Demand bank loans	`ShortTermBankLoansAndNotesPayable`	$174.93K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.22M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$2.90M	USD	Point-in-time
Accrued interest payable to shareholders	`InterestPayableRelatedPartiesCurrent`	$190.98K	USD	Point-in-time
Accrued interest payable to shareholders	`InterestPayableRelatedPartiesCurrent`	$21.17K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$227.72K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$542.45K	USD	Point-in-time
Deferred grant revenue	`DeferredRevenueCurrent`	$223.54K	USD	Point-in-time
Notes payable to shareholders, net of unamortized discount	`NotesPayableRelatedPartiesClassifiedCurrent`	$150.00K	USD	Point-in-time
Notes payable to shareholders, net of unamortized discount	`NotesPayableRelatedPartiesClassifiedCurrent`	$1.10M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$524.56K	USD	Point-in-time
Due to related party	`DueToRelatedPartiesCurrent`	$6.94K	USD	Point-in-time
Due to officers	`DueToOfficersOrStockholdersCurrent`	$3.20K	USD	Point-in-time
Due to officers	`DueToOfficersOrStockholdersCurrent`	$31.42K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.82M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.67M	USD	Point-in-time
Long-term notes, less current portion	`LongTermDebtNoncurrent`	$65.56K	USD	Point-in-time
Long-term notes, less current portion	`LongTermDebtNoncurrent`	$227.00K	USD	Point-in-time
Warrant liability	`DerivativeLiabilitiesNoncurrent`	$2.72M	USD	Point-in-time
Total liabilities	`Liabilities`	$5.62M	USD	Point-in-time
Total liabilities	`Liabilities`	$4.89M	USD	Point-in-time
Commitments and contingencies (Note 10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
0 preferred shares	`PreferredStockValue`	-	USD	Point-in-time
0 preferred shares	`PreferredStockValue`	-	USD	Point-in-time
27,209,646 common shares (16,000,000 at December 31, 2010)	`CommonStockValue`	$273.00	USD	Point-in-time
Capital in excess of par value	`AdditionalPaidInCapital`	$4.71M	USD	Point-in-time
Capital in excess of par value	`AdditionalPaidInCapital`	$3.60M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-5.69M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-7.91M	USD	Point-in-time
Non-controlling interest - consolidated subsidiary	`MinorityInterest`	$12.87K	USD	Point-in-time
Non-controlling interest - consolidated subsidiary	`MinorityInterest`	$-134.00	USD	Point-in-time
Total shareholders' deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-3.18M	USD	Point-in-time
Total shareholders' deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.09M	USD	Point-in-time
Total liabilities and shareholders' deficit	`LiabilitiesAndStockholdersEquity`	$2.44M	USD	Point-in-time
Total liabilities and shareholders' deficit	`LiabilitiesAndStockholdersEquity`	$2.80M	USD	Point-in-time

Income Statement 69 line items

Line Item	Tag	Value	Unit	Period
Revenue	`SalesRevenueNet`	$22.10K	USD	3 Qtrs
Revenue	`SalesRevenueNet`	$20.30K	USD	1 Quarter
Revenue	`SalesRevenueNet`	$801.64K	USD	3 Qtrs
Revenue	`SalesRevenueNet`	$529.37K	USD	1 Quarter
Other Income - Therapuertic Grant	`RevenueFromGrants`	$223.54K	USD	3 Qtrs
Other Income - Therapuertic Grant	`RevenueFromGrants`	$80.00K	USD	1 Quarter
Total revenue	`Revenues`	$20.30K	USD	1 Quarter
Total revenue	`Revenues`	$609.37K	USD	1 Quarter
Total revenue	`Revenues`	$1.03M	USD	3 Qtrs
Total revenue	`Revenues`	$22.10K	USD	3 Qtrs
Costs of goods sold	`CostOfGoodsSold`	$224.15K	USD	3 Qtrs
Costs of goods sold	`CostOfGoodsSold`	$5.30K	USD	1 Quarter
Costs of goods sold	`CostOfGoodsSold`	$6.30K	USD	3 Qtrs
Costs of goods sold	`CostOfGoodsSold`	$130.50K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$282.97K	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$712.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.51M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$67.53K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$451.09K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$138.91K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.38M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$383.58K	USD	3 Qtrs
Sales and marketing costs	`SellingAndMarketingExpense`	$267.81K	USD	3 Qtrs
Sales and marketing costs	`SellingAndMarketingExpense`	$37.11K	USD	1 Quarter
Amortization and depreciation	`DepreciationAndAmortization`	$40.80K	USD	1 Quarter
Amortization and depreciation	`DepreciationAndAmortization`	$132.43K	USD	3 Qtrs
Amortization and depreciation	`DepreciationAndAmortization`	$121.73K	USD	3 Qtrs
Amortization and depreciation	`DepreciationAndAmortization`	$44.63K	USD	1 Quarter
Costs and Expenses, Total	`CostsAndExpenses`	$794.58K	USD	3 Qtrs
Costs and Expenses, Total	`CostsAndExpenses`	$1.38M	USD	1 Quarter
Costs and Expenses, Total	`CostsAndExpenses`	$3.51M	USD	3 Qtrs
Costs and Expenses, Total	`CostsAndExpenses`	$252.54K	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-772.48K	USD	3 Qtrs
Operating loss	`OperatingIncomeLoss`	$-2.49M	USD	3 Qtrs
Operating loss	`OperatingIncomeLoss`	$-765.94K	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-232.24K	USD	1 Quarter
Gain warrant liability - derivative	`DerivativeGainOnDerivative`	$337.50K	USD	1 Quarter
Gain warrant liability - derivative	`DerivativeGainOnDerivative`	$337.50K	USD	3 Qtrs
Shareholders	`InterestExpenseRelatedParty`	$66.03K	USD	1 Quarter
Shareholders	`InterestExpenseRelatedParty`	$187.43K	USD	3 Qtrs
Shareholders	`InterestExpenseRelatedParty`	$9.40K	USD	1 Quarter
Shareholders	`InterestExpenseRelatedParty`	$28.18K	USD	3 Qtrs
Other	`InterestExpenseOther`	$12.53K	USD	1 Quarter
Other	`InterestExpenseOther`	$31.09K	USD	3 Qtrs
Other	`InterestExpenseOther`	$2.61K	USD	1 Quarter
Other	`InterestExpenseOther`	$24.94K	USD	3 Qtrs
Nonoperating Income (Expense), Total	`NonoperatingIncomeExpense`	$315.57K	USD	1 Quarter
Nonoperating Income (Expense), Total	`NonoperatingIncomeExpense`	$-68.64K	USD	1 Quarter
Nonoperating Income (Expense), Total	`NonoperatingIncomeExpense`	$284.38K	USD	3 Qtrs
Nonoperating Income (Expense), Total	`NonoperatingIncomeExpense`	$-218.52K	USD	3 Qtrs
Net loss	`ProfitLoss`	$-300.88K	USD	1 Quarter
Net loss	`ProfitLoss`	$-2.21M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-991.00K	USD	3 Qtrs
Net loss	`ProfitLoss`	$-450.37K	USD	1 Quarter
Net (income) loss attributable to non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-4.00	USD	3 Qtrs
Net (income) loss attributable to non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$14.71K	USD	1 Quarter
Net (income) loss attributable to non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$13.00K	USD	3 Qtrs
Net loss attributed to common shareholders	`NetIncomeLoss`	$-300.88K	USD	1 Quarter
Net loss attributed to common shareholders	`NetIncomeLoss`	$-465.08K	USD	1 Quarter
Net loss attributed to common shareholders	`NetIncomeLoss`	$-2.22M	USD	3 Qtrs
Net loss attributed to common shareholders	`NetIncomeLoss`	$-991.00K	USD	3 Qtrs
Loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.08	USD	3 Qtrs
Loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	1 Quarter
Loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	1 Quarter
Loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.09	USD	3 Qtrs
Common shares used in basic earnings per share calculation	`WeightedAverageNumberOfSharesOutstandingBasic`	11.23M	shares	3 Qtrs
Common shares used in basic earnings per share calculation	`WeightedAverageNumberOfSharesOutstandingBasic`	15.32M	shares	1 Quarter
Common shares used in basic earnings per share calculation	`WeightedAverageNumberOfSharesOutstandingBasic`	26.26M	shares	3 Qtrs
Common shares used in basic earnings per share calculation	`WeightedAverageNumberOfSharesOutstandingBasic`	27.21M	shares	1 Quarter

Cash Flow Statement 74 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-300.88K	USD	1 Quarter
Net loss	`ProfitLoss`	$-2.21M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-991.00K	USD	3 Qtrs
Net loss	`ProfitLoss`	$-450.37K	USD	1 Quarter
Amortization and depreciation	`DepreciationAndAmortization`	$40.80K	USD	1 Quarter
Amortization and depreciation	`DepreciationAndAmortization`	$132.43K	USD	3 Qtrs
Amortization and depreciation	`DepreciationAndAmortization`	$121.73K	USD	3 Qtrs
Amortization and depreciation	`DepreciationAndAmortization`	$44.63K	USD	1 Quarter
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$32.33K	USD	3 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$4.00K	USD	3 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$114.50K	USD	3 Qtrs
Gain warrant liability - derivative	`DerivativeGainOnDerivative`	$337.50K	USD	1 Quarter
Gain warrant liability - derivative	`DerivativeGainOnDerivative`	$337.50K	USD	3 Qtrs
Equity based employee compensation expense	`ShareBasedCompensation`	$327.46K	USD	3 Qtrs
Equity based employee compensation expense	`ShareBasedCompensation`	$134.81K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$86.68K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$40.60K	USD	3 Qtrs
Grant receivable	`IncreaseDecreaseInOtherReceivables`	$-223.54K	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$262.48K	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$524.73K	USD	3 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$-129.29K	USD	3 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$23.25K	USD	3 Qtrs
Deposits	`IncreaseDecreaseInDepositOtherAssets`	$-1.53K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-65.81K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$8.96K	USD	3 Qtrs
Accrued interest payable to shareholders	`IncreaseDecreaseInDueToOfficersAndStockholders`	$-163.10K	USD	3 Qtrs
Accrued interest payable to shareholders	`IncreaseDecreaseInDueToOfficersAndStockholders`	$61.99K	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$314.72K	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$172.20K	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-223.54K	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$20.30K	USD	3 Qtrs
Net cash used by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.47M	USD	3 Qtrs
Net cash used by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-650.52K	USD	3 Qtrs
Acquisition of patents and trademarks	`PaymentsToAcquireIntangibleAssets`	$88.38K	USD	3 Qtrs
Acquisition of patents and trademarks	`PaymentsToAcquireIntangibleAssets`	$570.64K	USD	3 Qtrs
Acquisition of office furniture and fixtures	`PaymentsToAcquireFurnitureAndFixtures`	$9.11K	USD	3 Qtrs
Net cash used by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-579.75K	USD	3 Qtrs
Net cash used by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-88.38K	USD	3 Qtrs
Payment of deferred private placement costs	`PaymentsOfStockIssuanceCosts`	$58.97K	USD	3 Qtrs
Payment on demand loan	`RepaymentsOfShortTermDebt`	$7.38K	USD	3 Qtrs
Proceeds from issuance of notes and warrants to shareholders	`ProceedsFromIssuanceOfNotesAndWarrants`	$485.00K	USD	3 Qtrs
Proceeds from issuance of notes and warrants to shareholders	`ProceedsFromIssuanceOfNotesAndWarrants`	$215.00K	USD	3 Qtrs
Payments on borrowings - notes payable to shareholders	`RepaymentsOfNotesPayable`	$4.39K	USD	3 Qtrs
Payments on borrowings - notes payable to shareholders	`RepaymentsOfNotesPayable`	$458.27K	USD	3 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$411.60K	USD	3 Qtrs
Net proceeds from January 25, 2011 private placement	`ProceedsFromIssuanceOrSaleOfEquity`	$3.29M	USD	3 Qtrs
Net payments to related party	`ProceedsFromRepaymentsOfRelatedPartyDebt`	$-21.27K	USD	3 Qtrs
Net payments to related party	`ProceedsFromRepaymentsOfRelatedPartyDebt`	$-93.70K	USD	3 Qtrs
Net advances from officers	`ProceedsFromPaymentsForOtherFinancingActivities`	$28.22K	USD	3 Qtrs
Net advances from officers	`ProceedsFromPaymentsForOtherFinancingActivities`	$7.87K	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$3.06M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$740.03K	USD	3 Qtrs
Net increase in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$1.13K	USD	3 Qtrs
Net increase in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$4.07K	USD	3 Qtrs
Cash - beginning of period	`Cash`	$158.00	USD	Point-in-time
Cash - beginning of period	`Cash`	$4.38K	USD	Point-in-time
Cash - beginning of period	`Cash`	$1.29K	USD	Point-in-time
Cash - beginning of period	`Cash`	$310.00	USD	Point-in-time
Cash - end of period	`Cash`	$158.00	USD	Point-in-time
Cash - end of period	`Cash`	$4.38K	USD	Point-in-time
Cash - end of period	`Cash`	$1.29K	USD	Point-in-time
Cash - end of period	`Cash`	$310.00	USD	Point-in-time
Cash paid during the period for interest	`InterestPaidNet`	$191.52K	USD	3 Qtrs
Cash paid during the period for interest	`InterestPaidNet`	$8.83K	USD	3 Qtrs
Payment of accounts payable for patent costs	`PaymentOfAccountsPayableForPatentCosts`	$500.00K	USD	3 Qtrs
Payment of accounts payable for deferred private placement costs	`PaymentOfAccountsPayableForDeferredPrivatePlacementCosts`	$526.13K	USD	3 Qtrs
Accounts payable converted to promissory notes	`ConversionOfAccountsPayableToNotePayable`	$587.00K	USD	3 Qtrs
Supplemental Accounts Payable, Total	`SupplementalAccountsPayable`	$1.61M	USD	3 Qtrs
Deferred private placement costs charged to contributed capital	`DeferredPrivatePlacementCostsChargedToContributedCapital`	$587.13K	USD	3 Qtrs
Conversion of member note to common shares and warrants	`DebtConversionOriginalDebtAmount1`	$614.07K	USD	3 Qtrs
Conversion of member note to common shares and warrants	`DebtConversionOriginalDebtAmount1`	$31.31K	USD	3 Qtrs
Issuance of warrants as derivative liability instruments and reduction of capital in excess of par value	`IssuanceOfDerivativeLiabilityInstrumentsAndReductionOfAdditionalPaidInCapital`	$3.06M	USD	3 Qtrs
Patent and trademark additions included in accounts payable	`PatentAndTrademarkAdditionsIncludedInAccountsPayable`	$20.95K	USD	3 Qtrs
Deferred private placement cost additions included in accounts payable	`DeferredPrivatePlacementCostAdditionsIncludedInAccountsPayable`	$293.96K	USD	3 Qtrs

Stockholders Equity 11 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-3.18M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.09M	USD	Point-in-time
Distribution of 5,000,000 warrants for common stock, exercise price of $3.00 per share	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$-1.55M	USD	3 Qtrs
Common Shares issued in January 25, 2011 private placement	`StockIssuedDuringPeriodValueNewIssues`	$2.34M	USD	3 Qtrs
Stock based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$327.46K	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$-300.88K	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-2.21M	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$-991.00K	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$-450.37K	USD	1 Quarter
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-3.18M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.09M	USD	Point-in-time

Comprehensive Income 2 line items

Line Item	Tag	Value	Unit	Period
Distribution of warrants for common stock, warrants	`NumberOfCommonStockWarrantsDistributedToShareholders`	5.00M	shares	3 Qtrs
Distribution of warrants for common stock, exercise price	`InvestmentWarrantsExercisePrice`	$3.00	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.